Further Reading
Abraham, SN, Jonsson, A-B and Normark, S (1998) Fimbriae-mediated host-
pathogen cross-talk. Curr. Opin. Microbiol.1: 75–81.Abuhammour, W and Habte-Gaber, E (2004) Newer antifungal agents. Indian
J. Pediatr.71: 253–259.Andrews, TM (2003) Current concepts in antibiotic resistance. Curr. Opin.
Otolaryngol. Head Neck Surg.11: 409–415.Barrett, B, Ebah, L and Roberts, IS (2002) Genomic structure of capsular
determinants. Curr. Top. Microbiol. Immunol.1: 137–155.Chakraborty, C, Nandi, S and Jana, S (2005) Prion disease: a deadly disease
for protein misfolding. Curr. Pharm. Biotechnol.6: 167–177.Chambers, HF (2003) Solving staphylococcal resistance to B-lactams. Trends
Microbiol.11: 135–148.Frayha, GI, Smyth, ID, Gobert, JG and Savel, J (1997) The mechanisms of
action of antiprotozoal and anthelmintic drugs in man. Gen. Pharmacol. 28:
273–299.Frieden, TR, Sterling, TR, Munsiff, SS, Watt, CJ and Dye, C (2003) Tuberculosis.
Lancet 362 : 887–899.Gould, D (2004) Bacterial infections: antibiotics and decontamination. Nurs.
Stand.18: 38–42.Hagan, P, Projan, S and Rosamond, J (2002) Infectious diseases: back to the
future? Trends Microbiol.10: S1–S2.Hayden, FG (2006) Antiviral resistance in influenza viruses – Implications for
management and pandemic response. N. Engl. J. Med.354: 785–788.Krcmery, VC (2005) Antifungal chemotherapeutics. Med. Princ. Pract.14:
125–135.Lipsitich, M (2001) The rise and fall of antimicrobial resistance. Trends
Microbiol.9: 438–444.Papageorgiou, AC and Acharya, KR (2000) Microbial superantigens: from
structure to function. Trends Microbiol.8: 369–375.Prinz, C, Hafsi, N and Voland, P (2003) Helicobacter pylori virulence factors
and the host immune response: implications for therapeutic vaccination.
Trends Microbiol.11: 134–138.Prusiner, SB (2003) Prion Biology and Diseases. University of California, USA.Putman, M, van Veen, HW and Konings, WN (2000) Molecular properties of
bacterial multidrug transporters. Microbiol. Mol. Biol. Rev.64: 672–693.Razin, S, Yogev, D and Naot, Y (1998) Molecular biology and pathogenicity of
mycoplasmas. Microbiol. Mol. Biol. Rev.62: 1094–1156.Rhen, M, Eriksson, S, Clements, M, Bergström, S and Normark, J (2003) The
basis of persistent bacterial infections. Trends Microbiol.11: 80–86.Rover, JK, Vats, V, Uppal, G and Yadav, S (2001) Anthelmintics: a review. Trop.
Gastroenterol.22: 180–189.Seeger, C and Mason, WS (2000) Hepatitis B virus biology. Microbiol. Mol. Biol.
Rev.64: 51–68.Sharma, R, Sharma, CL and Kapoor, B (2005) Antibacterial resistance: current
problems and possible solutions. Indian J. Med. Sci.59: 120–129.X]VeiZg(/ INFECTIOUS DISEASES AND TREATMENTS
,% W^dad\nd[Y^hZVhZ